Asia Medical and Agricultural Laboratory and Research Center Valuation
Is AMARC-F undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of AMARC-F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: AMARC-F (THB2.9) is trading above our estimate of fair value (THB1)
Significantly Below Fair Value: AMARC-F is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for AMARC-F?
Other financial metrics that can be useful for relative valuation.
What is AMARC-F's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | ฿604.80m |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 1.7x |
Enterprise Value/EBITDA | 8.8x |
PEG Ratio | 1x |
Price to Earnings Ratio vs Peers
How does AMARC-F's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 21.3x | ||
STI Stonehenge Inter | 49.2x | n/a | ฿2.0b |
BTC Brooker Group | 8.1x | n/a | ฿4.8b |
BOL Business Online | 19.1x | n/a | ฿5.4b |
UBA Utility Business Alliance | 8.8x | n/a | ฿618.0m |
AMARC-F Asia Medical and Agricultural Laboratory and Research Center | 30.1x | 28.9% | ฿604.8m |
Price-To-Earnings vs Peers: AMARC-F is expensive based on its Price-To-Earnings Ratio (30.1x) compared to the peer average (21.3x).
Price to Earnings Ratio vs Industry
How does AMARC-F's PE Ratio compare vs other companies in the Asian Professional Services Industry?
Price-To-Earnings vs Industry: AMARC-F is expensive based on its Price-To-Earnings Ratio (30.1x) compared to the Asian Professional Services industry average (20.6x).
Price to Earnings Ratio vs Fair Ratio
What is AMARC-F's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 30.1x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate AMARC-F's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.